Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy.

被引：0
|
作者：
Ghidini, Michele
Hahne, Jens Claus
Senti, Chiara
Tomasello, Gianluca
Ratti, Margherita
Heide, Timon
Garrone, Ornella
Cortellini, Alessio
Passalacqua, Rodolfo
Valeri, Nicola
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Med Oncol, Milan, Italy
[2] Inst Canc Res, London, England
[3] Hosp Cremona, Div Med Oncol, ASST Cremona, Cremona, Italy
[4] Human Technopole, Milan, Italy
[5] Imperial Coll London, Div Surg & Canc, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
    Ghidini, M.
    Hahne, J. C.
    Senti, C.
    Tomasello, G.
    Ratti, M.
    Heide, T.
    Garrone, O.
    Cortellini, A.
    Passalacqua, R.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [2] Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
    Ghidini, Michele
    Hahne, Jens Claus
    Senti, Chiara
    Heide, Timon
    Proszek, Paula Z.
    Shaikh, Ridwan
    Carter, Paul
    Hubank, Mike
    Trevisani, Francesco
    Garrone, Ornella
    Cappelletti, Maria Rosa
    Generali, Daniele
    Cattaneo, Monica
    Gnocchi, Nicoletta
    Donati, Gianvito
    Gobbi, Angela
    Grizzi, Giulia
    Lampis, Andrea
    Elghadi, Raghad
    Tanzi, Giulia
    Tomasello, Gianluca
    Ratti, Margherita
    Pinato, David J.
    Fassan, Matteo
    Vlachogiannis, Georgios
    Sottoriva, Andrea
    Cortellini, Alessio
    Passalacqua, Rodolfo
    Valeri, Nicola
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 707 - 718
  • [3] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Predictors for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Loree, Jonathan M.
    Davis, Jennifer S.
    Lam, Michael
    Morris, Van Karlyle
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Fogelman, David R.
    Sanchez, Eduardo Vilar
    Shureiqi, Imad
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab
    Parseghian, Christine Megerdichian
    Beutner, Karl
    Boedigheimer, Michael
    Ruff, Paul
    Price, Timothy Jay
    Kim, Tae Won
    Fakih, Marwan
    Ang, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] Clinical utility of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)
    Lim, Yoojoo
    Kim, Sheehyun
    Kang, Jun-Kyu
    Kim, Hwang-Phil
    Roh, Hanseong
    Kim, Su Yeon
    Lee, Dongin
    Bang, Duhee
    Jeong, Seung-Yong
    Park, Kyu Joo
    Han, Sae-Won
    Kim, Tae-You
    ANNALS OF ONCOLOGY, 2022, 33 : S507 - S507
  • [7] Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Jia, Jingquan
    Loree, Jonathan M.
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Overman, Michael J.
    Raymond, Victoria M.
    Lanman, Richard B.
    Talasaz, AmirAli
    Strickler, John H.
    Corcoran, Ryan Bruce
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy.
    Aoki, Yu
    Nakamura, Yoshiaki
    Komatsu, Yoshito
    Taniguchi, Hiroya
    Sunakawa, Yu
    Shiozawa, Manabu
    Kitagawa, Chiyoe
    Ohta, Takashi
    Matsuhashi, Nobuhisa
    Yamazaki, Kentaro
    Boku, Shogen
    Takahashi, Naoki
    Esaki, Taito
    Kawakami, Hisato
    Kagawa, Yoshinori
    Nishina, Tomohiro
    Yamaguchi, Kensei
    Bando, Hideaki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 157 - 157
  • [9] CIRCULATING TUMOUR DNA (ctDNA) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (mCRC): PROGNOSTIC SIGNIFICANCE AND EARLY CHANGES DURING CHEMOTHERAPY
    Tie, J.
    Kinde, I.
    Wong, H. -L.
    McKendrick, J.
    Singh, M.
    Karapetis, C.
    Desai, J.
    Tran, B.
    Roebert, J.
    Kinzler, K.
    Vogelstein, B.
    Gibbs, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 50 - 50
  • [10] Venous thromboembolism in advanced ovarian cancer patients undergoing front-line adjuvant chemotherapy.
    Pant, Alok
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345